Cargando…
De novo Vogt-Koyanagi-Harada disease after vaccination for COVID-19, successfully treated with systemic steroid therapy and monitored with laser speckle flowgraphy
PURPOSE: Vogt-Koyanagi-Harada (VKH) disease after vaccination for coronavirus disease 2019 (COVID-19) is rare, and the prognosis for this condition and its effect on ocular blood flow remains unclear. The purpose of this paper is to present the first case of de novo VKH disease after the second vacc...
Autores principales: | Yamaguchi, Chiaki, Kunikata, Hiroshi, Hashimoto, Kazuki, Yoshida, Masaaki, Ninomiya, Takahiro, Hariya, Takehiro, Abe, Toshiaki, Nakazawa, Toru |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9187874/ https://www.ncbi.nlm.nih.gov/pubmed/35719316 http://dx.doi.org/10.1016/j.ajoc.2022.101616 |
Ejemplares similares
-
Treatment of Vogt-Koyanagi-Harada Disease
por: Alaql, Musab K, et al.
Publicado: (2020) -
Tofacitinib in Vogt-Koyanagi-Harada disease
por: Dutta Majumder, Parthopratim, et al.
Publicado: (2020) -
An Unusual Presentation of Vogt–Koyanagi–Harada
por: Ipek, Sefik Can, et al.
Publicado: (2021) -
Vogt-Koyanagi-Harada Disease and COVID
por: Manni, Priscilla, et al.
Publicado: (2023) -
Rituximab in refractory Vogt–Koyanagi–Harada disease
por: Dolz-Marco, Rosa, et al.
Publicado: (2011)